Cost-effectiveness of adding oseltamivir to primary care for influenza-like-illness: economic evaluation alongside the randomised controlled ALIC(4)E trial in 15 European countries
在初级保健中添加奥司他韦治疗流感样疾病的成本效益:与15个欧洲国家的随机对照ALIC(4)E试验同时进行的经济评估
期刊:European Journal of Health Economics
影响因子:3
doi:10.1007/s10198-022-01521-2
Li, Xiao; Bilcke, Joke; van der Velden, Alike W; Bruyndonckx, Robin; Coenen, Samuel; Bongard, Emily; de Paor, Muirrean; Chlabicz, Slawomir; Godycki-Cwirko, Maciek; Francis, Nick; Aabenhus, Rune; Bucher, Heiner C; Colliers, Annelies; De Sutter, An; Garcia-Sangenis, Ana; Glinz, Dominik; Harbin, Nicolay J; Kosiek, Katarzyna; Lindbæk, Morten; Lionis, Christos; Llor, Carl; Mikó-Pauer, Réka; Radzeviciene Jurgute, Ruta; Seifert, Bohumil; Sundvall, Pär-Daniel; Touboul Lundgren, Pia; Tsakountakis, Nikolaos; Verheij, Theo J; Goossens, Herman; Butler, Christopher C; Beutels, Philippe